PATRICK DRUMMOND: Open Payments
NPI 1295936821 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 13 payments from 11 companies in 2025. Trend: 2023 $55 · 2024 $904 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Amgen Inc. | 1 | $82 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| Reprise Biomedical, Inc. | 1 | $35 |
| Smith+Nephew, Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FREESTYLE LIBRE 3, AIRSUPRA, REPATHA, TRELEGY ELLIPTA, Miro3D, COLLAGENASE SANTYL, Kerendia, INGREZZA.
Industry payments across TN — which companies pay providers there.
